Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Glenmark Pharma gets USFDA nod for Diltiazem Hydrochloride ER Capsules

Ruchika Sharma23 March 2021 12:28 PM IST

Mumbai: Drug major, Glenmark Pharmaceuticals Limited, today announced that the company has received final approval by the United States Food &...

Virchow Biotech to produce up to 200 million Sputnik V doses per year in India

Ruchika Sharma23 March 2021 11:00 AM IST

Moscow: Russia's RDIF sovereign wealth fund said on Monday it had reached an agreement with India's Virchow Biotech to produce up to 200 million doses...

Glenmark Pharma, Bausch Health collaborate to commercialize nasal spray Ryaltris in Canada

Ruchika Sharma23 March 2021 10:00 AM IST

Mumbai: Pharma major, Glenmark Pharmaceuticals, has recently announced that the company's subsidiary Glenmark Specialty S.A. in Switzerland and an...

NPPA regulates prices of 81 medicines including off-patent anti-diabetic drugs

Ruchika Sharma22 March 2021 2:03 PM IST

New Delhi: National Pharmaceutical Pricing Authority (NPPA) has fixed the price of 81 medicines including off-patent anti-diabetic drugs allowing due...

Sale of prescription drugs by e-pharmacies illegal: Trader's body CAIT writes to Govt

Ruchika Sharma22 March 2021 1:32 PM IST

New Delhi: Trader's body CAIT has written to the government alleging violation of the Drugs & Cosmetics Act by sale of pharmacy through e-commerce...

Serum Institute to delay COVID-19 vaccine shipments to Brazil, Morocco, Saudi due to rising demand at home

Ruchika Sharma22 March 2021 12:00 PM IST

New Delhi: The Serum Institute of India (SII) has told Brazil, Saudi Arabia and Morocco that further supplies of the AstraZeneca Covid-19 vaccine will...

Zaara Biotech bags USD 10 million investment from UAE

Ruchika Sharma22 March 2021 11:00 AM IST

Kochi: A student biotech startup has bagged an investment of USD 10 million from UAE-based TCN International Commerce L.L.C for its project...

South Africa sells AstraZeneca COVID-19 vaccines to other African Union member states

Ruchika Sharma22 March 2021 10:00 AM IST

After pausing the roll-out of the AstraZeneca vaccine, South Africa started inoculating healthcare workers with Johnson & Johnson shots in a research...

Bristol Myers Squibb submission for Mavacamten to treat Obstructive Hypertrophic Cardiomyopathy accepted by USFDA

Ruchika Sharma21 March 2021 10:45 AM IST

Princeton: Pharma major, Bristol Myers Squibb, has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted its New Drug...

Nepal gives Emergency Use Authorization to Covaxin

Ruchika Sharma21 March 2021 10:30 AM IST

Kathmandu: Nepal's drug regulatory body has approved India's Covaxin jab against Covid-19 for Emergency Use Authorization (EUA).Nepal's EUA approval...

Janssen Pharma gets USFDA nod for Ponvory to treat relapsing multiple sclerosis

Ruchika Sharma21 March 2021 10:15 AM IST

New Jersy: The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (USFDA) approved PONVORY...

Premas Biotech, Oramed Pharma together to develop oral COVID-19 vaccine effective after single dose

Ruchika Sharma21 March 2021 10:00 AM IST

Gurugram Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, has recently announced the development of an oral COVID-19...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok